R&D Worrying signs for trial diversity require broad industry ac... A recent report found that diversity in clinical trials has dropped.
Views & Analysis Addressing leadership barriers for women in tech and pharma Contrary to Big Tech, historically the pharmaceutical industry has had a good reputation for being a female-positive industry.
News J&J jumps on the MFN pricing train Johnson & Johnson is the latest pharma group to agree a Most-Favoured Nation (MFN) drug pricing deal with the Trump administration to avert tariffs.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
